Sign in

CIK 0001515673

  • Large accelerated filer

Ultragenyx Pharmaceutical Inc.

Sign in to watch
Ticker
RARE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272546083
Phone
+1 415-483-8800
Business address
60 LEVERONI COURT, NOVATO, CA, 94949
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$127,561
in 3 filings, $17K under 10b5-1 plans

Net −$127,561. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-06-19 Harris Erik EVP & Chief Commercial Officer Sale −295 $54.78 $16K 36,160
2022-04-19 Ray Amrit Director Grant or award +5,120 5,120
2022-04-19 Ray Amrit Director Grant or award · Stock Option (Right to Buy) +9,525 9,525
2022-04-16 Huizenga Theodore Alan SVP, Chief Accounting Officer Sale −132 $84.55 $11K 16,914
2022-03-11 Kassberg Thomas Richard CBO & EVP Sale −10,281 $67.01 $689K 227,559
2022-03-07 Parschauer Karah Herdman EVP and Chief Legal Officer Sale −5,140 $62.95 $324K 34,438
2022-03-04 Fust Matthew K Director Option exercise +7,500 $40.37 $303K 23,195
2022-03-04 Fust Matthew K Director Option exercise · Stock Option (Right to Buy) −7,500 0
2022-03-03 Dier Mardi CFO & Executive Vice President Sale −420 $64.55 $27K 51,808
2022-03-01 Dier Mardi CFO & Executive Vice President Sale −534 $66.62 $36K 38,228
2022-03-01 Dier Mardi CFO & Executive Vice President Grant or award +14,000 52,228
2022-03-01 Dier Mardi CFO & Executive Vice President Grant or award · Stock Option (Right to Buy) +24,900 24,900
2022-03-01 Harris Erik EVP & Chief Commercial Officer Sale −2,713 $66.62 $181K 22,317
2022-03-01 Harris Erik EVP & Chief Commercial Officer Grant or award +14,000 36,317
2022-03-01 Harris Erik EVP & Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +24,900 24,900
2022-03-01 Pinion John Richard See Remarks Sale −4,498 $66.62 $300K 45,266
2022-03-01 Pinion John Richard See Remarks Grant or award +14,000 59,266
2022-03-01 Pinion John Richard See Remarks Grant or award · Stock Option (Right to Buy) +24,900 24,900
2022-03-01 Huizenga Theodore Alan SVP, Chief Accounting Officer Sale −843 $66.62 $56K 13,229
2022-03-01 Huizenga Theodore Alan SVP, Chief Accounting Officer Grant or award +3,710 17,046

Page 16 of 21 · 410 trades